• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: August 27-31, 2012

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

August 27-31, 2012
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs8/27/31- 8/31/12N/AN/AN/ANo Significant Meetings
John M. Taylor, III, J.D., Counselor to the Commissioner8/27/12- 8/31/12N/AN/AN/ANo Significant Meetings
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy8/27/12- 8/31/12N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs8/27/12- 8/31/12 N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs8/27/12- 8/31/12N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products8/27/12- 8/31/12 N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Chief Counsel8/27/12- 8/31/12N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning8/29/12- 8/31/12N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine8/30/12Rockville, MDWilliam Flynn, Diane HeinzDorothy Gray, Tristan Colonius, Donald Hoenig, Kaylee Myhre (American Veterinary Medical Association)Center for Veterinary Medicine Overview
Jesse Goodman, M.D., M.P.H., Chief Scientist8/27/12- 8/31/12 N/AN/AN/ANo Significant Meetings
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition8/27/12- 8/31/12N/AN/AN/ANo Significant Meetings
Walter Harris, Chief Operating Officer8/27/12- 8/31/12N/AN/AN/ANo Significant Meetings
Jeanne Ireland, Associate Commissioner for Legislation8/27/12- 8/31/12N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research8/27/12- 8/31/12N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health8/28/12Silver Spring, MDCourtney Lias, Carol Benson, Stayce Beck, Arleen  Pinkos, Alberto Gutierrez, William MaiselPatricia Shrader, Mark O'Donnell, Katie Szyman, Fran Kaufman, John Mastrototaro, Chip Zimliki (Medtronic)Artificial Pancreas
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research8/27/12- 8/31/12N/AN/AN/ANo Significant Meetings
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco8/29/12Silver Spring, MDDianne Murphy, Robert NelsonAndrew Emmett, Andy Womack (BIO); Janet Jenkins-Showalter (Genentech Roche); Chin Koemer (Novartis); Ron Portman (Bristol-Myers Squibb); AJ Allen (Eli Lilly); Sam Maldonado (Johnson & Johnson)ICH Guideline, "Clinical Investigation of Medicinal Products in the Pediatric Population, E-11"
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods8/27/12- 8/31/12N/AN/AN/ANo Significant Meetings
Mary Lou Valdez, Associate Commissioner for International Programs8/28/12- 8/29/12Washington, DCN/ASeveral representatives from the Pan American Health Organization (PAHO)5 year Strategic Plan for Drug Regulatory Authorities
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs8/27/12- 8/31/12N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research8/28/12Silver Spring, MDLisa LaVange, Edward CoxDavid Fiedland (Cerexa, INC); Danny Benjamin (Duke University); John Tomyako (GlaxoSmithKline)Brookings Council on Antibacterial Drug Development